about
Nucleophosmin regulates the stability and transcriptional activity of p53Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VIBRAF mutations in hairy-cell leukemiaEML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissuesDistinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosminCytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell LeukemiaConfirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarrayClinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphomaTranslocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemiasNucleophosmin is required for DNA integrity and p19Arf protein stabilityNPM1 deletion is associated with gross chromosomal rearrangements in leukemiaMutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification.Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, UgandaExpression of the cytoplasmic NPM1 mutant (NPMc+) causes the expansion of hematopoietic cells in zebrafish.A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study.Nucleophosmin mutations alter its nucleolar localization by impairing G-quadruplex binding at ribosomal DNATumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT).Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype.Anaplastic large cell lymphoma: pathological, molecular and clinical features.Hodgkin's lymphoma: the pathologist's viewpointIdentification of novel DNA-damage tolerance genes reveals regulation of translesion DNA synthesis by nucleophosmin.Subclonal evolution of a classical Hodgkin lymphoma from a germinal center B-cell-derived mantle cell lymphoma.Pathobiology of primary mediastinal B-cell lymphoma.Evolving concepts in the pathogenesis of hairy-cell leukaemia.Light chain plasmacytoid lymphocytic lymphoma.Ber-ACT8: new monoclonal antibody to the mucosa lymphocyte antigen.The genetics of nodal marginal zone lymphomaPeripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia.Management of anaemia in oncohaematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective study.Acute myeloid leukemia with mutated nucleophosmin (NPM1): is it a distinct entity?Lymphoma classification: the quiet after the storm.T regulatory cell separation for clinical application.Mutational landscape of AML with normal cytogenetics: biological and clinical implications.Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization.Mouse models of NPM1-mutated acute myeloid leukemia: biological and clinical implications.Perspectives for therapeutic targeting of gene mutations in acute myeloid leukaemia with normal cytogenetics.
P50
Q24300176-010A913C-6FDC-4021-9F9E-9C65B991E9F2Q24318928-29BC0E4B-6963-44A5-8054-12B405F9A216Q24609980-89FC9505-889C-487D-AE0C-FFC06DC34999Q24645724-78E7F3B8-D601-4FBC-8FEC-00B1FE036248Q24652323-51F7EB10-B6AA-4C0D-8DD1-5AC2D14C6710Q27824827-9B2BF1E0-3DE8-48AA-B086-600DA90E9EAAQ27853209-30B43236-B3AF-4AE5-8773-E1F9C98736DCQ28204313-A3002E09-227A-48A4-9A08-EBE8047B31AAQ28209540-096C3B10-E22B-4ABC-959A-38273E273B45Q28301353-2A557E9A-117A-41F8-B85D-6D38DCB4DED9Q28593126-E8789EE5-8263-4090-851C-45D209460D75Q28749228-AC8A333F-810E-4D32-B5CE-C32C3A320147Q33254865-114D205C-625A-4E48-A931-89C207FC08B9Q33518060-E03FF7D6-9005-4D51-BA9F-E5F7A49A54D0Q33806096-C570ADAC-335C-428F-B9FC-0310D35CAED6Q33822032-B00BA524-515A-4ADD-A527-5B6B41CE77F3Q34035133-08321D8F-614E-43FD-95CC-5587FD269D68Q34139220-A67219CE-D55A-4848-9233-99528F4068FCQ34217060-EB2D0383-124A-4AB4-97A1-929F59A21C7BQ34225646-C8CD9ADC-7668-4EF0-B201-6AC00E7261C1Q34374218-4A3B393C-59DD-43A7-9A44-AB099A3E0567Q34564836-69B02CC2-52E2-4E61-9F8C-721C0F580ED4Q34679192-09E155F5-D49C-46A6-9F98-CC1862D62753Q34912276-C12A5FC5-F57A-4E7A-B8F6-E352237FA38AQ35808376-BEA83BCB-312D-4437-A11F-BC1818824A49Q36488725-F49B89B6-2E4D-418D-8E54-25176D606784Q36716773-B79BDA67-ACA8-4A04-93B6-A3C8E5CD66C5Q37140381-C71C25E7-89EE-4534-B0E4-BD971E058D01Q37243257-856C6EE7-11FD-48D9-9906-B38968278EFEQ37255632-F7438BBE-E820-46CE-8BBA-B29EFFAEC68AQ37514846-06A879C1-7C71-4C2C-9AC3-0A266A8E2416Q37623386-0EE26614-E5D6-45A4-8B6C-B8F273ED22A5Q37632227-8F467079-1546-4C60-B68A-61ABEF4E5875Q37804639-FB446526-C492-4D64-9030-C2D3037C65D5Q37917733-D77323F2-0C9E-4E8B-B499-B9A3E392FA2BQ38026324-FBD25F54-A5C0-4198-878B-FC0535C47F62Q38069315-A57DC0AF-6A17-4CBE-8640-86D56B9DF1A5Q38084251-A0E82937-48B5-41D5-A27F-D5229825C504Q38245417-33631D90-1678-4D1E-B344-2C7578756B9BQ38428692-28CEA884-D3B1-4481-A833-86373EC0D936
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Brunangelo Falini
@ast
Brunangelo Falini
@en
Brunangelo Falini
@es
Brunangelo Falini
@nl
type
label
Brunangelo Falini
@ast
Brunangelo Falini
@en
Brunangelo Falini
@es
Brunangelo Falini
@nl
prefLabel
Brunangelo Falini
@ast
Brunangelo Falini
@en
Brunangelo Falini
@es
Brunangelo Falini
@nl
P106
P1153
7006446786
P21
P31
P496
0000-0002-7198-5965